trūFreeze® Palliative Esophageal Cancer

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

November 6, 2017

Primary Completion Date

July 13, 2022

Study Completion Date

March 6, 2024

Conditions
Esophageal Cancer
Interventions
DEVICE

trūFreeze® System spray cryotherapy

Subjects where trūFreeze® System spray cryotherapy is performed

Trial Locations (10)

11030

North Shore-Long Island Jewish Medical Center, Manhasset

14642

University of Rochester, Rochester

23298

Virginia Commonwealth University, Richmond

27599

University of North Carolina at Chapel Hill, Chapel Hill

30322

Emory University, Atlanta

46845

Parkview Comprehensive Cancer Center, Fort Wayne

49546

Spectrum Health, Grand Rapids

85338

Cancer Treatment Centers of America Western Regional Medical Center, Goodyear

92868

University of California at Irvine, Orange

03756

Dartmouth-Hotchcock Medical Center, Lebanon

All Listed Sponsors
lead

US Endoscopy Group Inc.

INDUSTRY

NCT03243734 - trūFreeze® Palliative Esophageal Cancer | Biotech Hunter | Biotech Hunter